Moulting and hatching in nematodes; the role of astacin metalloproteases as potential anti-nematode targets

Lead Research Organisation: University of Glasgow
Department Name: Veterinary Infection and Immunity

Abstract

Parasitic nematodes are a major pest of plants and animals. Around 1 billion people, predominantly in the developing world, harbour parasitic nematodes that cause chronic and debilitating diseases. In addition, nematodes cause a significant economic burden to agriculture, affecting crops and livestock throughout the world. Methods to control nematodes are relatively limited, and drug resistance is becoming common. All nematodes share a common lifecycle growing from an egg through 4 immature larval stages before reaching the sexually mature adult stage. Progression from egg to larvae involves a hatching process, and from individual larval stages to adulthood involves a repeated process termed moulting, where the external skeleton is shed and a new one synthesised. The moulting process allows growth. The astacin enzymes are catalysts that are involved in the processes of hatching, skeleton synthesis and moulting. The specific roles played by this class of enzymes have been confirmed in a model experimental system and will now be examined and characterized in an important veterinary parasite. The nematode Haemonchus contortus is a common and economically significant parasite of sheep and goats. Information gained in this system will also be of relevance in other parasites of animals and plants. The project aims are to identify, study and exploit these enzymes with the overall goal of identifying vaccine and drug targets to treat and control nematode infections.

Technical Summary

Parasitic nematodes infect man, his domestic animal and crops and represent a significant medical, veterinary and agricultural burden. Trichostrongylid infections of livestock are widespread causing morbidity, death and economic losses. Effective antihelminthic drugs are limited and multiple resistance is emerging thus highlighting the need to identify novel targets and new means of nematode control. All nematodes undergo a set developmental pathway from the egg through 4 larval stages before reaching the sexually mature adult stage. Progression from embryo to larvae involves a hatching process, and from individual larval stages to adulthood involves a repeated process termed moulting, where the collagenous cuticle is shed and a new one synthesised. The astacin class of enzymes are key players in the nematode-specific processes of hatching, exoskeleton synthesis and moulting. The specific roles played by the nematode-specific subclass V astacins have been confirmed in the Caenorhabditis elegans model experimental system and will now be examined in the veterinary parasite Haemonchus contortus. This project will identify and functionally characterize the H. contortus class V astacins. Information gained in this system will be of relevance in other nematode parasites of animals and plants, and will be aimed at characterizing and exploiting these enzymes with the overall goal of identifying vaccine and drug targets to treat and control nematode infections.
 
Description Parasitic nematodes are a major pest of plants and animals. Around 1 billion people, predominantly in the developing world, harbour parasitic nematodes that cause chronic and debilitating diseases. In addition, nematodes cause a significant economic burden to agriculture, affecting crops and livestock throughout the world. Methods to control nematodes are relatively limited, and drug resistance is becoming common. All nematodes share a common lifecycle growing from an egg through 4 immature larval stages before reaching the sexually mature adult stage. Progression from egg to larvae involves a hatching process, and from individual larval stages to adulthood involves a repeated process termed moulting, where the external skeleton is shed and a new one synthesised. The moulting process allows growth and development.
The astacin enzymes are catalysts that are involved in the processes of hatching, exoskeleton synthesis and moulting. The specific roles played by this class of enzymes were originally established in a model experimental system (Caenorhabditis elegans) and have now been validated in an important veterinary parasite. The nematode Haemonchus contortus is a common and economically significant gastrointestinal parasite of sheep and goats. The results generated in the H. contortus and C. elegans systems are also relevant to other parasites of animals and plants, and this has now been established for the human infective filarial nematode Brugia malayi. The project aims were to identify, study and exploit these enzymes with the overall goal of identifying vaccine and drug targets to treat and control nematode infections.
In this study we have successfully identified and characterized the key enzymes that are involved in the synthesis and remodelling of the exoskeleton of both Haemonchus contortus and Brugia malayi. We have proven that they play nematode-specific roles, key criteria for the development of a potential drug or vaccine. In addition, we have developed a range of experimental tools that will be invaluable in future targeted drug development; these include a nematode transgenic complementation system, a recombinant protein expression system and specific protease and collagenase assays.
In this project we have successfully developed a nematode complementation system, whereby existing C. elegans cuticle and moulting mutants can be rescued via transgenesis with parasitic nematode genes. This has been done for Haemonchus contortus genes, and for the first time with Brugia malayi genes. This had led to the development of numerous transgenic C. elegans lines that express H. contortus and B. malayi astacins, peroxidase and protease inhibitor genes. This resource will be invaluable in future targeted drug development studies.

We have also developed a novel autoinduction protocol for the expression of H. contortus and B. malayi recombinant proteins in a functionally active form. This information will be of interest to other groups working in this field.

We have also developed a nematode cuticle collagen-processing assay that will be used to screen for collagen processing enzymes and their inhibitors. Again, this will be a useful resource for future targeted drug development.
Exploitation Route In this project we have successfully developed a nematode complementation system, whereby existing C. elegans cuticle and moulting mutants can be rescued via transgenesis with parasitic nematode genes. This has been done for Haemonchus contortus genes, and for the first time with Brugia malayi genes. This had led to the development of numerous transgenic C. elegans lines that express H. contortus and B. malayi astacins, peroxidase and protease inhibitor genes. This resource will be invaluable in future targeted drug development studies.

We have also developed a novel autoinduction protocol for the expression of H. contortus and B. malayi recombinant proteins in a functionally active form. This information will be of interest to other groups working in this field.

We have also developed a nematode cuticle collagen-processing assay that will be used to screen for collagen processing enzymes and their inhibitors. Again, this will be a useful resource for future targeted drug development.
Sectors Agriculture, Food and Drink,Education,Healthcare

 
Description Our findings have been taken forward in a follow on application to identify compounds that may be developed as novel anthelmintics.
First Year Of Impact 2012
Sector Agriculture, Food and Drink,Education
 
Description BBSRC Project Grant panel A responsive mode
Amount £358,690 (GBP)
Funding ID bb/I011218/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 09/2011 
End 09/2014
 
Description VIP award
Amount £22,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2008 
End 05/2009